A detailed history of Godsey & Gibb Associates transactions in Becton Dickinson & CO stock. As of the latest transaction made, Godsey & Gibb Associates holds 790 shares of BDX stock, worth $179,290. This represents 0.02% of its overall portfolio holdings.

Number of Shares
790
Previous 790 -0.0%
Holding current value
$179,290
Previous $184,000 3.26%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$225.07 - $246.17 $22,507 - $24,617
-100 Reduced 11.24%
790 $184,000
Q2 2023

Jul 25, 2023

BUY
$238.39 - $265.32 $10,727 - $11,939
45 Added 5.33%
890 $234,000
Q1 2023

Apr 18, 2023

BUY
$229.71 - $259.35 $194,104 - $219,150
845 New
845 $209,000
Q1 2021

May 13, 2021

SELL
$232.09 - $256.88 $187,064 - $207,045
-806 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $178,867 - $198,227
806 New
806 $202,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Godsey & Gibb Associates Portfolio

Follow Godsey & Gibb Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.